ted Dr. Burzynski to bring his research and manufacturing facil- ity into compliance with FDA's current 3. 21 US.C. § 351(a)(2)03). EFTA00191827 U.S. I. BURZYNSKI CANCER RESEARCH INSTITUTE 1305 Chew 019 Fad 1301 (kb Clr. 1987) good-manufacturing procedures, ordering ter to make copies. On the advice of his the FDA in turn to act pr